|
|
||||||||
1 Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago 60611; 4 Department of Mathematics, Northeastern Illinois University, Chicago, Illinois 60625; 2 Department of Medicine, Technion, Israel Institute of Technology, 31096 Haifa, Israel; and 3 Departamento de Enfermedades Respiratorias, Facultad de Medicina, Universidad Católica de Chile, Santiago, Chile
| |
ABSTRACT |
|---|
|
|
|---|
During hydrostatic pulmonary edema,
active Na+ transport and alveolar fluid reabsorption are
decreased. Dopamine (DA) and isoproterenol (ISO) have been shown to
increase active Na+ transport in rat lungs by upregulating
Na+-K+-ATPase in the alveolar epithelium. We
studied the effects of DA and ISO in isolated rat lungs with increased
left atrial pressure (Pla = 15 cmH2O) compared with
control rats with normal Pla (Pla = 0). Alveolar fluid
reabsorption decreased from control value of 0.51 ± 0.02 to
0.27 ± 0.02 ml/h when Pla was increased to 15 cmH2O
(P < 0.001). DA and ISO increased the alveolar fluid
reabsorption back to control levels. Treatment with the D1
antagonist SCH-23390 inhibited the stimulatory effects of DA (0.30 ± 0.02 ml/h), whereas fenoldopam, a specific D1-receptor
agonist, increased alveolar fluid reabsorption in rats exposed to Pla
of 15 cmH2O (0.47 ± 0.04 ml/h). Propranolol, a
-adrenergic-receptor antagonist, blocked the stimulatory effects of
ISO; however, it did not affect alveolar fluid reabsorption in control
or DA-treated rats. Amiloride (a Na+ channel blocker) and
ouabain (a Na+-K+-ATPase inhibitor), either
alone or together, inhibited the stimulatory effects of DA. Colchicine,
which disrupts the cellular microtubular transport of ion-transporting
proteins to the plasma membrane, inhibited the stimulatory effects of
DA, whereas the isomer
-lumicolchicine did not block the stimulatory
effects of DA. These data suggest that DA and ISO increase alveolar
fluid reabsorption in a model of increased Pla by regulating active
Na+ transport in rat alveolar epithelium. The effects of DA
and ISO are mediated by the activation of dopaminergic D1
receptors and the
-adrenergic receptors, respectively.
active sodium transport; cytoskeleton
| |
INTRODUCTION |
|---|
|
|
|---|
PULMONARY EDEMA DEVELOPS as a result of either changes in the hydrostatic and/or oncotic pressure gradients across the pulmonary circulation or increased alveolocapillary permeability. As such, increased pulmonary capillary wedge pressures can result in pulmonary edema formation (13, 32). Several therapeutic options are available in clinical practice to reduce edema formation; however, approaches to increase alveolar fluid reabsorption (once edema has been formed) are less understood. Previous reports have suggested that vectorial Na+ transport and thus alveolar fluid reabsorption across the alveolocapillary barrier are important in keeping the air spaces free of edema (16, 23, 29). Alveolar fluid reabsorption is regulated in epithelial cells by the rate of sodium entry, via the apical Na+ channels, coupled to the rate of Na+ extrusion, via the basolateral Na+-K+-ATPase.
Dopamine (DA) induces natriuresis in the kidney by inhibiting the Na+-K+-ATPase. However, in the lungs, DA and isoproterenol (ISO) have been shown to increase active Na+ transport and thus alveolar fluid reabsorption in normal rats as well as in rats exposed to hyperoxia by regulating Na+-K+-ATPase function in the alveolar epithelium (3, 4, 27).
Recently, it has been shown that alveolar fluid reabsorption is impaired in the presence of elevated left atrial pressures (Pla) (Refs. 7 and 22, and Saldias FJ, Azzam ZS, Ridge KM, Yeldandi A, Rutschman DH, Schraufnagel D, Sznajder JI, unpublished observations). The purpose of this study was to determine whether DA and ISO would increase alveolar fluid reabsorption in a model of increased Pla and investigate mechanisms contributing to these effects.
| |
METHODS AND MATERIALS |
|---|
|
|
|---|
Isolated-perfused lung.
The lungs and heart of rats anesthetized with 50 mg/kg body wt
of intraperitoneal pentobarbital were removed en bloc after a 10-min
ventilation with 100% O2 and anticoagulation with heparin as previously described (23, 28). The pulmonary artery and left atrium were catheterized and perfused continuously with a solution
of 3% bovine serum albumin (BSA) in buffered physiological salt
solution (135.5 mM Na+, 119.1 mM Cl
, 25 mM
HCO3
, 4.1 mM K+, 2.8 mM Mg+,
2.5 mM Ca2+, 0.8 mM SO4
2, 8.3 mM
glucose). Trace amounts of fluorescein-labeled (FITC) albumin were also
added to the perfusate. The recirculating volume of the
constant-pressure perfusion system was 90 ml; arterial and venous
pressures were set at 15 and 0 cmH2O, respectively, in the
group of rats with normal Pla and 20 and 15 cmH2O,
respectively, in the increased Pla study groups. The vascular pressures
were recorded every 10 s with a multichannel recorder (Cyber
Sense, Nicholasville, KY). The lungs were immersed in a "pleural"
bath (100 ml) filled with the same BSA solution. The entire system was
maintained at 37°C in a water bath. Perfusate pH was maintained at
7.40 by bubbling with a gas mixture of 95% O2-5%
CO2. The lungs were then instilled via tracheal cannula in
two sequential phases with a total of 5-ml volume of the BSA solution
containing 0.1 mg/ml Evans blue dye-labeled (EBD; Sigma Chemical, St.
Louis, MO) albumin, 0.02 µCi/ml of 22Na+ (Du
Pont-NEN, Boston, MA) and 0.12 µCi/ml of [3H]mannitol
(Du Pont-NEN). Samples were taken from the instillate, perfusate, and
bath solutions after an equilibration time of 10 min from the
instillation and 60 min later. To ensure a homogeneous sampling of the
instillate, a volume of 2 ml was aspirated and reintroduced into the
air spaces three times before each sample was removed. All samples were
centrifuged at 3,000 g for 10 min. Absorbance analysis of
the supernatant or EBD albumin was performed at 620 nm in a Hitachi
model U2000 spectrometer (Hitachi, San Jose, CA). Analysis of
FITC-albumin (excitation 487 nm and emission 520 nm) was performed in a
Perkin-Elmer fluorometer (model LS-3B, Perkin-Elmer, Oakbrook, IL).
Scintillation counts (for 22Na+ and
[3H]mannitol) were measured in a Beckman beta counter
(model LS 6500, Beckman Instruments, Fullerton, CA).
Calculations.
The mathematical calculation of lung liquid clearance, the movement of
sodium, and the flux of mannitol were described elsewhere (23). Briefly, the amount of instilled EBD-albumin remains
constant during the experimental protocol; thus any change in its
concentration at a given time (t) will reflect the change in
the air space volume (Vt)
|
(1) |
|
(2) |
|
(3) |
|
(4) |
|
(5) |
Study groups.
One hundred nineteen specific pathogen-free male Sprague-Dawley rats
(275-325 g) were acquired from Harlan Sprague Dawley (Indianapolis, IN). DA, ISO, SCH-23390, colchicine, and
-lumicolchicine were purchased from Sigma Chemical. Ouabain and
propranolol were purchased from RBI (Natick, MA), and fenoldopam was
generously provided by Neurex (Menlo Park, CA).
Control group of rats studied at Pla 0 cmH2O (n = 7) and Pla 15 cmH2O (n = 7).
Rat lungs were instilled with 10
4 M DA into the air space
at Pla 0 cmH2O (n = 8) and Pla 15 cmH2O (n = 7). Rat lungs were perfused with
10
6 M ISO through the pulmonary circulation at Pla 0 cmH2O (n = 6) and Pla 15 cmH2O
(n = 6).
6 M
fenoldopam, a specific D1-receptor agonist, into rat air
spaces exposed to Pla 15 cmH2O (n = 6). We
also studied the effect of dopaminergic receptor-1 antagonist SCH-23390
by instilling rat lungs with 10
4 M SCH-23390 into the air
space at Pla 15 cmH2O either alone (n = 3) or with 10
4 M DA (n = 4).
To evaluate the
-adrenergic pathway, we instilled the
-adrenergic
blocker 10
4 M propranolol into the rat air spaces at Pla
15 cmH2O either alone (n = 5) or in the
presence of 10
4 M DA (n = 5) or ISO
10
6 M (n = 5).
To examine the contributory role of the amiloride-sensitive
Na+ pathways and basolateral
Na+-K+-ATPase on dopaminergic effects, we
instilled 10
4 M amiloride (Na+ channel
blocker) into the rat air spaces (n = 4) and perfused the lungs with 5 × 10
4 M ouabain
(Na+-K+-ATPase blocker) either alone
(n = 7) or both agents together (n = 6)
in rat lungs exposed to Pla 15 cmH2O and in the presence of
DA (amiloride + DA, n = 4, ouabain + DA,
n = 6, and both antagonists with DA, n = 4) in rat lungs with Pla 15 cmH2O.
To evaluate the role of cell microtubular transport system on alveolar
fluid reabsorption modulation by dopamine, we studied rats treated with
colchicine (0.25 mg/100 g body wt) injected intraperitoneally 15 h
before the experiments at Pla 15 cmH2O either alone
(n = 5) or with 10
4 M DA
(n = 6) instilled into the rat air spaces. We also
studied the effects of 0.25 mg/100 g body wt of
-lumicolchicine
injected intraperitoneally 15 h before the experiments at Pla 15 cmH2O either alone (n = 4) or with
10
4 M DA (n = 4) instilled into the rat
air spaces.
-Lumicolchicine is an isomer of colchicine that does not
bind tubulin and does not depolymerize microtubules; however, it shares
other properties of colchicine, such as inhibition of protein synthesis
(37).
Statistical analysis. Data are presented as means ± SE; n is the number of animals in each study group. One-way analysis of variance was used when multiple comparisons were made followed by a multiple comparison test (Tukey's) when the F statistic indicated significance. Results were considered significant when P < 0.05.
| |
RESULTS |
|---|
|
|
|---|
Alveolar fluid reabsorption.
As depicted in Fig. 1, alveolar fluid
reabsorption in rat lungs exposed to Pla of 15 cmH2O was
decreased by ~45% compared with control rats with Pla of 0 cmH2O (from 0.51 ± 0.02 to 0.27 ± 0.02 ml/h,
P < 0.001). Treatment with DA or ISO restored alveolar fluid reabsorption to control levels in rat lungs exposed to elevated Pla (0.44 ± 0.03 and 0.52 ± 0.02 ml/h, respectively).
|
6
M fenoldopam (a specific D1 agonist) were instilled into
the air spaces. Fenoldopam increased alveolar fluid reabsorption to control levels (0.47 ± 0.04 ml/h). As shown in Fig.
2A, instillation of the
specific D1 antagonist SCH-23390 in the rat air spaces prevented the DA-mediated increase in alveolar fluid reabsorption. As
depicted in Fig. 2B, the instillation of the
-adrenergic-receptor antagonist 10
4 M propranolol
inhibited the stimulatory effects of ISO; however, in DA-treated lungs,
propranolol did not affect the rate of alveolar fluid reabsorption.
|
4 M amiloride into the air spaces and/or the perfusion
of 5 × 10
4 M ouabain in the pulmonary circulation
inhibited alveolar fluid reabsorption in rat lungs with Pla of 15 cmH2O. These data suggest that DA increased alveolar
fluid reabsorption in this model by regulating the amiloride-sensitive
Na+ pathways and Na+-K+-ATPase in
the alveolar epithelium.
|
-lumicolchicine and then exposed to increased Pla compared with
control rats (from 0.51 to 0.18 ± 0.07 to 0.34 ± 0.01 ml/h). Treatment with DA increased alveolar fluid reabsorption in
-lumicolchicine-treated rats to 0.50 ± 0.04 ml/h but had no
effects in the colchicine-treated rats.
|
Epithelial permeability.
As shown in Table 1, alveolar
epithelial permeability to the small solutes, as measured by
22Na+ and
[3H+]mannitol flux, was significantly
increased in the rat lungs exposed to Pla of 15 cmH2O
compared with control rats. The movement of FITC-albumin from the
pulmonary circulation into the air spaces was slightly increased in all
rat lungs exposed to Pla 15 cmH2O compared with control
rats (Pla 0 cmH2O).
|
| |
DISCUSSION |
|---|
|
|
|---|
During congestive heart failure with increased Pla, patients can develop cardiogenic pulmonary edema. Recently, it has been shown that, in animal models of increased pulmonary vascular pressures, there is not only increased edema formation but also impairment of alveolar fluid reabsorption (7, 22, Saldias et al., unpublished observations). Additionally, in some patients with hydrostatic pulmonary edema, the alveolar fluid reabsorption was preserved, whereas in other patients, the ability to clear edema was impaired (35). We reason that, in patients suffering from chronic heart failure, the neurohumoral axis is activated, which results in increased endogenous catecholamines (8, 10, 30). Thus it is possible that, in patients with increased levels of endogenous catecholamines, alveolar fluid reabsorption is preserved (20, 21). We report here that, in an isolated rat lung model with acute increase in Pla, there was decreased alveolar fluid reabsorption. Our data are concordant with a previous report showing that the alveolar fluid clearance was normal in sheep exposed to moderate left atrial hypertension. In contrast, in adrenalectomized sheep where the secretion of endogenous catecholamines was abolished, the clearance was significantly reduced (7).
DA has been used clinically to induce natriuresis in patients with
pulmonary edema by inhibiting the Na+-K+-ATPase
activity in the renal tubular epithelium (17). In
contrast, DA enhanced active Na+ transport and increased
alveolar fluid reabsorption in normal rat lungs and in a model of lung
injury induced by exposure of rats to 100% oxygen for 64 h
(3, 27). In accord with these data, we are reporting that,
in a model of increased Pla, DA, via the D1 receptors, and
ISO, via activation of
-adrenergic receptors, increased alveolar
fluid reabsorption. These effects were blocked by the
D1-receptor antagonist SCH-23390 and increased by the
D1 agonist fenoldopam (Fig. 2A). The
-adrenergic-receptor antagonist propranolol did not inhibit the
stimulatory effects of DA (Fig. 2B). These results suggest
that the DA effects in this model are mediated by the dopaminergic
(D1) and not the
-adrenergic pathway.
The effects of DA and ISO were inhibited by ouabain and amiloride,
confirming that
-adrenergic and dopaminergic agonists increase lung
edema clearance by stimulating the alveolar epithelial Na+-K+-ATPase function and amiloride-sensitive
Na+ pathways in rat lungs with increased Pla (Fig. 3), as
has been previously reported in control rats (3, 4, 28).
Upregulation of Na+-K+-ATPase function could be
due to increased transcription, translation, protein assembly,
recruitment, and translocation to the plasma membrane from
intracellular pools and metabolic activation (5, 6).
Recent studies have suggested that the cell microtubular transport
system and cytoskeleton proteins are involved in Na+ pump
recruitment from intracellular pools to the plasma membrane (6). Therefore, we tested in physiological experiments
whether the stimulatory effects of DA and ISO in rat lungs exposed to increased Pla occur by stimulation of preexisting membrane-bound Na+ pumps or by recruitment of
Na+-K+- ATPase proteins from intracellular
pools to the cell plasma membrane. We reasoned that cell microtubular
transport disruption by colchicine could provide information about
whether the stimulatory effects of DA and ISO on active Na+
transport and lung edema clearance in rat lungs with increased Pla
could be due to Na+ pump recycling. We indeed observed that
colchicine inhibited DA stimulation of edema clearance in rat lungs
with increased Pla (Fig. 4). Meanwhile, the isomer
-lumicolchicine,
which shares many colchicine properties with the exception of
inhibiting cell microtubular transport (27, 28), did not
inhibit the DA modulation of lung edema clearance. These results
suggest that, in a model of increased Pla, DA and ISO upregulation of
lung edema clearance is mediated by recruitment of Na+
pumps from intracellular pools to the plasma membrane of alveolar epithelial cells.
The data presented in this report support the notion that increased pulmonary capillary hydrostatic pressures represent a model of lung injury that impairs alveolar fluid reabsorption. Our data agree with reports in sheep (7, 11) and rats (Saldias et al., unpublished observations) in which the rate of alveolar fluid reabsorption was impaired when hydrostatic pulmonary circulation pressures were increased.
The epithelial permeability to small solutes and to albumin was slightly increased compared with rat groups with normal Pla. These observations are similar to studies in which increased permeability of tracers across the alveolocapillary barrier was reported when Pla increased (19, 34, 36). We reason that this is possibly due to capillary stress failure or stretch pore phenomena that may transiently affect the permeability of the alveolocapillary barrier (2, 36).
This report demonstrates the beneficial effects of DA and ISO by improving alveolar fluid reabsorption in a model of increased hydrostatic pulmonary circulation pressures. Left heart failure with resultant decrease in effective arterial volume is characterized mainly by decreased cardiac output and left atrial enlargement (1, 14). Consequently, this may lead to increased levels of atrial natriuretic peptides, angiotensin II, endothelin, and possibly endogenous ouabain-like substances (12, 15, 24, 30). It has been reported that atrial natriuretic peptides instilled in the rat air spaces decreased the active Na+ transport and alveolar fluid reabsorption (18, 33). Also, endogenous ouabain-like substances may decrease alveolar fluid reabsorption by inhibiting alveolar Na+-K+-ATPase. We reason that DA and ISO can counteract these decreases in active Na+ transport and increase alveolar fluid reabsorption.
In summary, we report that DA and ISO increase alveolar fluid
reabsorption in a model of increased Pla. The effects of DA are
mediated by the activation of dopaminergic D1 receptors,
whereas the effects of ISO are mediated by the activation of
-adrenergic receptors that cause an upregulation of the
amiloride-sensitive Na+ pathways and
Na+-K+-ATPase. This new information is of
potential clinical relevance in the treatment of patients with
cardiogenic pulmonary edema.
| |
ACKNOWLEDGEMENTS |
|---|
This study was supported in part by National Heart, Lung, and Blood Institute Grants HL-48129 and HL-65161, National Research Service Award HL-09806, and Pontificia Universidad Catolica de Chile FONDECYT 1990515.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: J. I. Sznajder, Pulmonary and Critical Care Medicine, Northwestern Univ., Tarry 14-707, 300 E. Superior St., Chicago, IL 60611 (E-mail: j-sznajder{at}northwestern.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 3 May 2000; accepted in final form 12 September 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Anand, IS,
Ferrari R,
Kalra GS,
Wahi PL,
Poole-Wilson PA,
and
Harris PC.
Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure.
Circulation
80:
299-305,
1989
2.
Bachofen, H,
Schurch S,
and
Weibel ER.
Experimental hydrostatic pulmonary edema in rabbit lungs. Barrier lesions.
Am Rev Respir Dis
147:
997-1004,
1993[Web of Science][Medline].
3.
Barnard, ML,
Olivera WG,
Rutschman DM,
Bertorello AM,
Katz AI,
and
Sznajder JI.
Dopamine stimulates sodium transport and liquid clearance in rat lung epithelium.
Am J Respir Crit Care Med
156:
709-714,
1997
4.
Barnard, ML,
Ridge KM,
Saldias F,
Friedman E,
Gare M,
Guerrero C,
Lecuona E,
Bertorello AM,
Katz AI,
and
Sznajder JI.
Stimulation of the dopamine 1 receptor increases lung edema clearance.
Am J Respir Crit Care Med
160:
982-986,
1999
5.
Berthiaume, Y,
Staub NC,
and
Matthay MA.
Beta-adrenergic agonists increase lung liquid clearance in anesthetized sheep.
J Clin Invest
79:
335-343,
1987.
6.
Bertorello, AM,
Ridge KM,
Chibalin AV,
Katz AI,
and
Sznajder JI.
Isoproterenol increases Na+-K+-ATPase activity by membrane insertion of
-subunits in lung alveolar cells.
Am J Physiol Lung Cell Mol Physiol
276:
L20-L27,
1999
7.
Campbell, AR,
Folkesson HG,
Berthiaume Y,
Gutkowska J,
Suzuki S,
and
Matthay MA.
Alveolar epithelial fluid clearance persists in the presence of moderate left atrial hypertension in sheep.
J Appl Physiol
86:
139-151,
1999
8.
Cohn, JN,
Levine TB,
Francis GS,
and
Goldsmith S.
Neurohumoral control mechanisms in congestive heart failure.
Am Heart J
102:
509-514,
1981[Web of Science][Medline].
9.
Crandall, ED,
Heming TA,
Palombo RL,
and
Goodman BE.
Effects of terbutaline on sodium transport in isolated perfused rat lung.
J Appl Physiol
60:
289-294,
1986
10.
Francis, GS,
Goldsmith SR,
Levine TB,
Olivari MT,
and
Cohn JN.
The neurohumoral axis in congestive heart failure.
Ann Intern Med
101:
370-377,
1984.
11.
Frank, JA,
Wang Y,
Osorio O,
and
Matthay MA.
-Adrenergic agonist therapy accelerates the resolution of hydrostatic pulmonary edema in sheep and rats.
J Appl Physiol
89:
1255-1265,
2000
12.
Gottlieb, SS,
Rogowski AC,
Weinberg M,
Krichten CM,
Hamilton BP,
and
Hamlyn JM.
Elevated concentrations of endogenous ouabain in patients with congestive heart failure.
Circulation
86:
420-425,
1992
13.
Gropper, MA,
Wiener-Kronish JP,
and
Hashimoto S.
Acute cardiogenic pulmonary edema.
Clin Chest Med
15:
501-515,
1994[Web of Science][Medline].
14.
Katz, AM.
Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure.
N Engl J Med
322:
100-110,
1990[Web of Science][Medline].
15.
Luscher, TF.
Endothelin: systemic arterial and pulmonary effects of a new peptide with potent biologic properties.
Am Rev Respir Dis
146:
S56-S60,
1992[Web of Science][Medline].
16.
Matthay, MA,
Folkesson HG,
and
Verkman AS.
Salt and water transport across alveolar and distal airway epithelia in the adult lung.
Am J Physiol Lung Cell Mol Physiol
270:
L487-L503,
1996
17.
Meister, B,
and
Aperia A.
Molecular mechanisms involved in catecholamine regulation of sodium transport.
Semin Nephrol
13:
41-49,
1993[Web of Science][Medline].
18.
Olivera, W,
Ridge K,
Wood LD,
and
Sznajder JI.
ANF decreases active sodium transport and increases alveolar epithelial permeability in rats.
J Appl Physiol
75:
1581-1586,
1993
19.
Pietra, GG,
Szidon JP,
Leventhal MM,
and
Fishman AP.
Hemoglobin as a tracer in hemodynamic pulmonary edema.
Science
166:
1643-1646,
1969
20.
Pittet, JF,
Brenner TJ,
Modelska K,
and
Matthay MA.
Alveolar liquid clearance is increased by endogenous catecholamines in hemorrhagic shock in rats.
J Appl Physiol
81:
830-837,
1996
21.
Pittet, JF,
Wiener-Kronish JP,
McElroy MC,
Folkesson HG,
and
Matthay MA.
Stimulation of lung epithelial liquid clearance by endogenous release of catecholamines in septic shock in anesthetized rats.
J Clin Invest
94:
663-671,
1994.
22.
Raj, JU,
and
Bland RD.
Lung luminal liquid clearance in newborn lambs. Effect of pulmonary microvascular pressure elevation.
Am Rev Respir Dis
134:
305-310,
1986[Web of Science][Medline].
23.
Rutschman, DH,
Olivera W,
and
Sznajder JI.
Active transport and passive liquid movement in isolated perfused rat lungs.
J Appl Physiol
75:
1574-1580,
1993
24.
Sakai, S,
Miyauchi T,
Sakurai T,
Yamaguchi I,
Kobayashi M,
Goto K,
and
Sugishita Y.
Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist. Increased expression of endothelin-1 messenger ribonucleic acid and endothelin-1-like immunoreactivity in the lung in congestive heart failure in rats.
J Am Coll Cardiol
28:
1580-1588,
1996[Abstract].
26.
Saldias, FJ,
Comellas A,
Ridge KM,
Lecuona E,
and
Sznajder JI.
Isoproterenol improves ability of lung to clear edema in rats exposed to hyperoxia.
J Appl Physiol
87:
30-35,
1999
27.
Saldias, FJ,
Lecuona E,
Comellas AP,
Ridge KM,
and
Sznajder JI.
Dopamine restores lung ability to clear edema in rats exposed to hyperoxia.
Am J Respir Crit Care Med
159:
626-633,
1999
28.
Saldias, F,
Lecuona E,
Friedman E,
Barnard ML,
Ridge KM,
and
Sznajder JI.
Modulation of lung liquid clearance by isoproterenol in rat lungs.
Am J Physiol Lung Cell Mol Physiol
274:
L694-L701,
1998
29.
Saumon, G,
and
Basset G.
Electrolyte and fluid transport across the mature alveolar epithelium.
J Appl Physiol
74:
1-15,
1993
30.
Schrier, RW,
and
Abraham WT.
Hormones and hemodynamics in heart failure.
N Engl J Med
341:
577-585,
1999
31.
Soltoff, SP,
and
Mandel LJ.
Amiloride directly inhibits the Na+-K+-ATPase activity of rabbit kidney proximal tubules.
Science
220:
957-958,
1983
32.
Staub, NC.
Pulmonary edema.
Physiol Rev
54:
678-811,
1974
33.
Tharaux, PL,
Dussaule JC,
Couette S,
and
Clerici C.
Evidence for functional ANP receptors in cultured alveolar type II cells.
Am J Physiol Lung Cell Mol Physiol
274:
L244-L251,
1998
34.
Tsukimoto, K,
Yoshimura N,
Ichioka M,
Tojo N,
Miyazato I,
Marumo F,
Mathieu-Costello O,
and
West JB.
Protein, cell, and LTB4 concentrations of lung edema fluid produced by high capillary pressures in rabbit.
J Appl Physiol
76:
321-327,
1994
35.
Verghese, GM,
Ware LB,
Matthay BA,
and
Matthay MA.
Alveolar epithelial fluid transport and the resolution of clinically severe hydrostatic pulmonary edema.
J Appl Physiol
87:
1301-1312,
1999
36.
West, JB,
and
Mathieu-Costello O.
Vulnerability of pulmonary capillaries in heart disease.
Circulation
92:
622-631,
1995
37.
Wilson, L,
and
Friedkin M.
The biochemical events of mitosis. I. Synthesis and properties of colchicine labeled with tritium in its acetyl moiety.
Biochemistry
5:
2463-2468,
1966[Medline].
This article has been cited by other articles:
![]() |
S. G. Gandhi, B. Rafii, M. S. Harris, A. Garces, D. Mahuran, X.-J. Chen, H.-F. Bao, L. Jain, D. C. Eaton, G. Otulakowski, et al. Effects of cardiogenic edema fluid on ion and fluid transport in the adult lung Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L651 - L659. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Azzam, Y. Adir, L. Welch, J. Chen, J. Winaver, P. Factor, N. Krivoy, A. Hoffman, J. I. Sznajder, and Z. Abassi Alveolar fluid reabsorption is increased in rats with compensated heart failure Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L1094 - L1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Helms, J. Self, H. F. Bao, L. C. Job, L. Jain, and D. C. Eaton Dopamine activates amiloride-sensitive sodium channels in alveolar type I cells in lung slice preparations Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L610 - L618. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Litvan, A. Briva, M. S. Wilson, G. R. S. Budinger, J. I. Sznajder, and K. M. Ridge beta-Adrenergic Receptor Stimulation and Adenoviral Overexpression of Superoxide Dismutase Prevent the Hypoxia-mediated Decrease in Na,K-ATPase and Alveolar Fluid Reabsorption J. Biol. Chem., July 21, 2006; 281(29): 19892 - 19898. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Bertorello and J. I. Sznajder The Dopamine Paradox in Lung and Kidney Epithelia: Sharing the Same Target but Operating Different Signaling Networks Am. J. Respir. Cell Mol. Biol., November 1, 2005; 33(5): 432 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Mutlu and J. I. Sznajder Mechanisms of pulmonary edema clearance Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L685 - L695. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Matthay, L. Robriquet, and X. Fang Alveolar Epithelium: Role in Lung Fluid Balance and Acute Lung Injury Proceedings of the ATS, October 1, 2005; 2(3): 206 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kunzelmann, J. Konig, J. Sun, D. Markovich, N. J. King, G. Karupiah, J. A. Young, and D. I. Cook Acute Effects of Parainfluenza Virus on Epithelial Electrolyte Transport J. Biol. Chem., November 19, 2004; 279(47): 48760 - 48766. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Liebler, Z. Borok, X. Li, B. Zhou, A. J. Sandoval, K.-J. Kim, and E. D. Crandall Alveolar Epithelial Type I Cells Express {beta}2-Adrenergic Receptors and G-protein Receptor Kinase 2 J. Histochem. Cytochem., June 1, 2004; 52(6): 759 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Mutlu, V. Dumasius, J. Burhop, P. J. McShane, F. J. Meng, L. Welch, A. Dumasius, N. Mohebahmadi, G. Thakuria, K. Hardiman, et al. Upregulation of Alveolar Epithelial Active Na+ Transport Is Dependent on {beta}2-Adrenergic Receptor Signaling Circ. Res., April 30, 2004; 94(8): 1091 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Adir, Z. S. Azzam, E. Lecuona, S. Leal, L. Pesce, V. Dumasius, A. M. Bertorello, P. Factor, J. B. Young, K. M. Ridge, et al. Augmentation of Endogenous Dopamine Production Increases Lung Liquid Clearance Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 757 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sugita, P. Ferraro, A. Dagenais, M.-E. Clermont, P. Barbry, R. P. Michel, and Y. Berthiaume Alveolar Liquid Clearance and Sodium Channel Expression Are Decreased in Transplanted Canine Lungs Am. J. Respir. Crit. Care Med., May 15, 2003; 167(10): 1440 - 1450. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Comellas, L. M. Pesce, Z. Azzam, F. J. Saldias, and J. I. Sznajder Scorpion Venom Decreases Lung Liquid Clearance in Rats Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1064 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Matthay Alveolar Fluid Clearance in Patients With ARDS: Does It Make a Difference? Chest, December 1, 2002; 122 (2009): 340S - 343S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. I. Sznajder, P. Factor, and D. H. Ingbar Lung Edema Clearance: 20 Years of Progress: Invited Review: Lung edema clearance: role of Na+-K+-ATPase J Appl Physiol, November 1, 2002; 93(5): 1860 - 1866. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Ware, X. Fang, Y. Wang, T. Sakuma, T. S. Hall, and M. A. Matthay Lung Edema Clearance: 20 Years of Progress: Selected Contribution: Mechanisms that may stimulate the resolution of alveolar edema in the transplanted human lung J Appl Physiol, November 1, 2002; 93(5): 1869 - 1874. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sartori, X. Fang, D. W. McGraw, P. Koch, M. E. Snider, H. G. Folkesson, and M. A. Matthay Lung Edema Clearance: 20 Years of Progress: Selected Contribution: Long-term effects of beta 2-adrenergic receptor stimulation on alveolar fluid clearance in mice J Appl Physiol, November 1, 2002; 93(5): 1875 - 1880. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Fisher and S. S. Margulies Na+-K+-ATPase activity in alveolar epithelial cells increases with cyclic stretch Am J Physiol Lung Cell Mol Physiol, October 1, 2002; 283(4): L737 - L746. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Matthay, H. G. Folkesson, and C. Clerici Lung Epithelial Fluid Transport and the Resolution of Pulmonary Edema Physiol Rev, July 1, 2002; 82(3): 569 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Factor, Z. A. Azzam, G. M. Mutlu, J. I. Sznajder, and V. Dumasius Enhancement of Alveolar Epithelial {beta}2-Adrenergic Receptor Function Via Gene Transfer Chest, March 1, 2002; 121 (2009): 45S - 46S. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Azzam, V. Dumasius, F. J. Saldias, Y. Adir, J. I. Sznajder, and P. Factor Na,K-ATPase Overexpression Improves Alveolar Fluid Clearance in a Rat Model of Elevated Left Atrial Pressure Circulation, January 29, 2002; 105(4): 497 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Saldias, Z. S. Azzam, K. M. Ridge, A. Yeldandi, D. H. Rutschman, D. Schraufnagel, and J. I. Sznajder Alveolar fluid reabsorption is impaired by increased left atrial pressures in rats Am J Physiol Lung Cell Mol Physiol, September 1, 2001; 281(3): L591 - L597. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |